SFTPD and systemic sclerosis: Jee et al. [26] recently proposed a composite biomarker index comprising SP-D (surfactant protein D), CA15-3 (cancer antigen 15-3), and ICAM-1 (intercellular adhesion molecule 1) that can effectively identify SSc-ILD.